164980-59-0

Upstream product

• 42017-07-2 1-heptynyllithium 
• 164980-58-9 2-(3-dimethoxymethyl-phenyl)-oxirane 
• 37832-33-0 isophthalaldehyde bis-dimethylacetal 
• 100501-45-9 3-(dimethoxymethyl)benzaldehyde 
• 626-19-7 Isophthalaldehyde 

Downstream Products

• 164980-60-3 tert-butyl-[1-(3-dimethoxymethyl-phenyl)-non-3-ynyloxy]-diphenyl-silane 
• 164980-67-0 (Z)-6-{3-[(Z)-1-(tert-Butyl-diphenyl-silanyloxy)-non-3-enyl]-phenyl}-hex-5-enoic acid methyl ester 
• 164980-61-4 3-[1-(tert-butyl-diphenyl-silanyloxy)-non-3-ynyl]-benzaldehyde 
• 164980-66-9 3-[1-(tert-butyl-diphenyl-silanyloxy)-non-3-enyl]-benzaldehyde 
• 164980-68-1 1-[(1Z)-5-methoxycarbonylpent-1-enyl]-3-[(3Z)-1-hydroxynon-3-enyl]benzene 

Relevant academic research and scientific papers

Synthesis of novel aromatic analogues of 12-HETE

New mono- and diaromatic analogues of the arachidonic acid metabolite 12-HETE have been prepared using versatile strategies. The easily accessible monoacetal of isophtalaldehyde 3 was developed as a key intermediate for these syntheses.

Cyclised analogues of fatty acid metabolites

A compound selected from those of formula (I): STR1 wherein A, X, Y, Z, R, R1, R2, R3 and R4 are as defined in the description. This compound or its physiologically tolerable salts may be used therapeutically as platelet anti-aggregation agent.